Monica Prokoski
Vice President of Finance and Investor Relations
Replay available
LifeStance Health Group, Inc. (NASDAQ: LFST) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.

Vice President of Finance and Investor Relations
Chief Executive Officer
Chief Financial Officer
Analyst at Morgan Stanley
Analyst at JP Morgan
Analyst at William Blair
Analyst at Jefferies
Analyst at Canaccord Genuity
Analyst at UBS
Analyst at BTIG
Analyst at KeyBank Capital Markets
Ladies and gentlemen, thank you for standing by. My name is Colby, and I'll be your conference operator today. At this time, I would like to welcome you to the LifeStance Health third quarter 2025 earnings call. All lines have been placed on mute to prevent any background noise, and after the speaker's remarks, there will be a question and answer session. If you'd like to ask a question at that time, please press star, then the number one on your telephone keypad. If you'd like to withdraw your question at any time, please press star one again. Thank you. I would now like to turn the call over to Monica Prokoski. Please go ahead. Thank you, Operator. Good morning, everyone, and welcome to LifeStance Health's third quarter 2025 earnings conference call. I'm Monica Prokoski, Vice President of Finance and Investor Relations. Joining me today are Dave Borden, Chief Executive Officer, and Ryan McGrory, Chief Financial Officer. We issued the earnings release and presentation before the market opened this morning. Both are available on the investor relations section of our website, investor.lifesense.com. In addition, a replay will be available following the call. Before turning over to management for their prepared remarks, please direct your attention to the disclaimers about forward-looking statements included in the earnings press release and SEC filings. Today's remarks contain forward-looking statements, including statements about our financial performance outlook, business model, and strategy. Those statements involve risks, uncertainties, and other factors, as noted in our periodic filings with the SEC, that could cause actual results to differ materially. Please note that we report results using non-GAAP financial measures, which we believe provide additional infor...